Escalon® Medical Corp. Reports Second Quarter Fiscal 2015 Results
PR Newswire - Fri Feb 13, 8:04PM CST
Escalon Medical Corp. (NASDAQ: ESMC) today announced financial results for its second quarter of fiscal 2015, ended December 31, 2014.
ESMC: 1.21 (-0.02)
Global Retinal Surgery Devices Market 2015-2019 with Alcon, Bausch & Lomb, Iridex & Synergetics USA Dominating
M2 - Sat Jan 31, 1:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/vfpj68/global_retinal) has announced the addition of the "Global Retinal Surgery Devices Market 2015-2019" report to their offering. The Global Retinal Surgery Devices market to grow at a CAGR of 7.32% over the period 2014-2019. The human eye is the most vital sensory organ. Ophthalmic diagnostic devices are used to identify and rectify ophthalmic disorders such as presbyopia, cataracts, glaucoma, retinal disorders, conjunctivitis, and dry eyes. Common eye problems can be caused by an infection or can be congenital. Continuous advances in the technology of ophthalmic devices ensure efficient diagnosis and treatment. Ophthalmic devices play a major role in treating loss of vision and improving quality of life of patients. Increased use of vitrectomy machines in the treatment of retinal detachment and vitreous hemorrhage is one key trend in this market. This is because of the availability of high-quality vitrectomy machines in the market with a cutting speed of approximately 2,500 cuts/min. According to the report, increase in aging population is one of the major drivers in the market. The growing incidence of retinal disorders, such as diabetic retinopathy, AMD, macular degeneration, retinal tear, and retinal detachments among the elderly results in increased demand for retinal surgeries to prevent loss of vision. Further, the report states that the presence of substitutes for retinal surgeries is one of the major challenges that the market faces. There are several drugs available in the market for the treatment of retinal disorders. The Global Retinal Surgery Devices market is divided into four segments: Vitrectomy Packs, Retinal Lasers, Vitrectomy Machines and Others (Retinal implants, scleral buckles, light sources, light pipes, cryosurgery devices, retinal laser probes, and surgical instruments). Key Vendors - Alcon - Bausch & Lomb - Iridex - Synergetics USA Other Prominent Vendors - ASICO - Beaver-Visitec International - Biotech Visioncare - Carl Zeiss Meditec - Ellex Medical Lasers - Erbe Elektromedizin - Escalon Medical - Geuder - Insight Instruments - Lumenis - Nano Retina - Oertli Instrumente - Peregrine Surgical - Quantel Medical - Retina Implant - Rhein Medical - Second Sight Medical Products Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Product Type - Incidence and Prevalence of Retinal Disorders - Regulatory Environment - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/vf...al_retinal
EYES: 8.95 (-0.19), ESMC: 1.21 (-0.02)
Escalon Medical EPS of -$0.06
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 4:06PM CST
ESMC: 1.21 (-0.02)
Escalon® Medical Corp. Reports First Quarter Fiscal 2015 Results
PR Newswire - Fri Nov 14, 3:07PM CST
Escalon Medical Corp. (Nasdaq: ESMC) today announced its operating results for its fiscal 2015 first quarter ended September 30, 2014.
ESMC: 1.21 (-0.02)
Sonomed Escalon® Features Unique Trough Eyelid Diaton® Tonometer at the American Academy of Ophthalmology, AAO 2014, Chicago
PR Newswire - Tue Oct 14, 7:30AM CDT
Escalon Medical Corp. to feature transpalpebral Diaton tonometer at the American Academy of Ophthalmology, AAO 2014. Diaton tonometer will be featured alongside the Company's new VuPad(TM) ultrasound system. Diaton tonometry demo and training sessions available at Exhibit #526 with support from BiCOM Inc home of Diaton.
ESMC: 1.21 (-0.02)
Escalon® Medical posts lower net loss from continuing operations of USD349,532 fiscal 2014
M2 - Mon Sep 29, 6:27AM CDT
Diagnostic imaging company Escalon Medical (NasdaqCM:ESMC) disclosed on Friday that it had a net loss from continuing operations of USD349,532 (USD0.05 per share) for the fiscal year ended 30 September 2014.
ESMC: 1.21 (-0.02)
Escalon® Medical Corp. Reports Fiscal 2014 Results
PR Newswire - Fri Sep 26, 3:40PM CDT
Escalon Medical Corp. (NASDAQ: ESMC) today announced its operating results for the fiscal year ended September 30, 2014. The Company was also recently granted authority to apply the CE Mark to the Sonomed Escalon VuPad(TM), its new tablet-based ultrasound imaging system.
ESMC: 1.21 (-0.02)
Final Fantasy 14 Debuts China, Operated by Shanda Games
SinoCast - Wed Feb 26, 4:49AM CST
Shanda Games Limited (SDG; Nasdaq: GAME) CEO declared initiation of Chinese operation of Final Fantasy 14 developed by Square Enix. First test will be kicked off in April, marking the debut of the game on China.
JNJ: 99.62 (+1.18), OPK: 13.80 (-0.28), GAME: 5.18 (-0.04), ESMC: 1.21 (-0.02), COO: 165.20 (+2.18)
Escalon® Medical Corp. Reports Second Quarter Fiscal 2014 Results; New Product Introductions Underway
PR Newswire - Fri Feb 14, 3:05PM CST
Escalon Medical Corp. (Nasdaq: ESMC) today announced its operating results for the second fiscal quarter and six months ended December 31, 2013.
ESMC: 1.21 (-0.02)